Arrowhead Research Corporation ARWR
Analyst Ratings
- Consensus
- Buy — 11 Buy · 3 Hold · 0 Sell (14 analysts)
- Avg. Price Target
- $99.07 (+100.7% upside)
Key Stats
- Today's Range
- $47.66 – $49.74
- 50-Day Range
- $46.45 – $87.20
- 52-Week Range
- $34.61 – $95.49
- Volume
- 2.53 million shs
- Average Volume
- 1.96 million shs
- Market Cap
- $6.92 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 2.10%
- Days to Cover
- 2.29
About Arrowhead Research Corporation
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.
Related Stocks
Compare head-to-head: ARWR vs LLY·ARWR vs JNJ·ARWR vs ABBV·ARWR vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.